Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00061269 · ClinicalTrials.gov registry record · NA
Videoendoscopic Drainage of Infected Pancreatic Collections
A NA study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00061269 is a NA study that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 40 participants.
The verdict
NCT00061269, a NA study, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The VARD (Videoendoscopic Assisted Retroperitoneal Drainage) approach as treatment for necrotizing pancreatitis proposes an alternative to standard complicated open abdomen treatment methods. This treatment involves making a small incision and looking inside the abdomen with a videoendoscope. A videoendoscope is an instrument with a small camera and light on the end. It also has an extension tool that the surgeon can use to clean out any dead and infected tissue in the abdomen. This approach may reveal a treatment opportunity with faster recovery potential and shorter hospitalizations for patients with necrotizing pancreatitis.
Interventions
- PROCEDURE Videoscopic-Assisted Retroperitoneal Debridement (VARD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2003-09 |
| Est. Completion | 2008-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00061269
The ClinicalTrials.gov registry entry for NCT00061269 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Videoscopic-Assisted Retroperitoneal Debridement (VARD) is the first listed.
NCT00061269 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00061269 about?
NCT00061269 is a clinical study titled "Videoendoscopic Drainage of Infected Pancreatic Collections". The VARD (Videoendoscopic Assisted Retroperitoneal Drainage) approach as treatment for necrotizing pancreatitis proposes an alternative to standard complicated open abdomen treatment methods. This treatment involves making a small incision and looking inside the abdomen with a videoendoscope. A vid...
What is the current status of trial NCT00061269?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2003-09. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00061269?
The interventions under investigation include: Videoscopic-Assisted Retroperitoneal Debridement (VARD) (PROCEDURE).
Who is sponsoring clinical trial NCT00061269?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.